TK008

TK008

Randomized phase III trial of Haploidentical HCT with or without add back strategy of HSV-Tk Donor Lymphocytes in patiens with high risk Acute Leukemia


Treatment


Inclusion criteria


Exclusion criteria


Participating sites



Link